Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma

AK, GÜNTÜLÜ; Metintas, SELMA; METİNTAŞ, MUZAFFER; YILDIRIM, HÜSEYİN; Erginel, MEHMET; KURT, EMEL; ALATAŞ, FÜSUN; Cadirci, Omer

doi:10.1097/jto.0b013e3181ba2033

Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma

Copy For Citation

AK G., Metintas S., METİNTAŞ M., YILDIRIM H., Erginel S., KURT E., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.4, no.11, pp.1425-1430, 2009 (SCI-Expanded)

Publication Type: Article / Article
Volume: 4 Issue: 11
Publication Date: 2009
Doi Number: 10.1097/jto.0b013e3181ba2033
Journal Name: JOURNAL OF THORACIC ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1425-1430
Keywords: Malignant pleural mesothelioma, Prognostic factors, Treatment schedule, EUROPEAN-ORGANIZATION, LUNG-CANCER, PHASE-III, SURVIVAL, CHEMOTHERAPY, OSTEOPONTIN, VALIDATION, EXPERIENCE, CISPLATIN
Eskisehir Osmangazi University Affiliated: Yes

Abstract

Objectives: In this study, we aimed to investigate the factors affecting the survival of patients with malignant pleural mesothelioma (MPM) according to their treatment schedules, including those treated with best supportive care, chemotherapy, and multimodality therapy.